EXEL
Exelixis, Inc.
NASDAQ · Healthcare · Biotechnology · US
$59.01
−0.20%Margins
Gross margin
96.5%
EBITDA margin
42.7%
EBIT margin
39.9%
Net margin
35.3%
FCF margin
48.5%
46.7%
Return on equity
34.5%
Return on assets
48.3%
Return on invested capital
0.96x
Asset turnover
$1.2B
Cash from operations
$3.39
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jul 1, 2026